CLVT_OUT_1 [2025-04-29 10:01:41 -0400] 4970 Bytes | 1377 tokens | Cum: 1377 tkns (17.21% of 8k)
==========================================================================

Hearken to the bells of 10:01 AM on Tue Apr 29, 2025, for Clarivate (CLVT) stirreth—ascending from $3.59 to $4.21. Shall we strike whilst the iron is hot, or bide our time in patience?

--- COMPANY PROFILE ---
Company: Clarivate (CLVT)
IPO: 2019-05-14 (5 Years Ago)
Market Cap: $2,276,999,953
Shares Outstanding: 688,960,000
Industry: SERVICES-COMPUTER PROCESSING & DATA PREPARATION
Exchange: XNYS
Description: Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.

Here’s a list of headlines for Clarivate:

Today 07:15AM - Clarivate PLC (CLVT) Q1 Earnings and Revenues Surpass Estimates
06:00AM - Clarivate Reports First Quarter 2025 Results
Apr-25-25 03:00PM - Booking Holdings to Report Q1 Earnings: What Should Investors Do?
Apr-25-25 03:00PM 11:32AM - Snap to Report Q1 Earnings: Key Metrics and Expectations to Watch
Apr-23-25 10:01AM - Earnings Preview: Unisys (UIS) Q1 Earnings Expected to Decline
Apr-23-25 10:01AM 10:01AM - Charter Communications to Post Q1 Earnings: What's in the Cards?
Apr-23-25 10:01AM 04:00AM - Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution
Apr-23-25 10:01AM 03:00AM - Clarivate Releases EndNote 2025 with AI-Powered Research Tools
Apr-22-25 10:01AM - Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: Should You Buy?
Apr-17-25 11:02PM - Clarivate Plc (CLVT): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025
Apr-09-25 06:38PM - Analyst Report: Clarivate Plc
Apr-09-25 06:38PM 03:00AM - Clarivate Expands its Academic AI Platform, Introducing Agentic AI for Research and Learning
Apr-08-25 06:42PM - Analyst Report: Clarivate Plc
Apr-02-25 08:05AM - Clarivate to Report First Quarter 2025 Results on April 29, 2025
Mar-31-25 07:55PM - Is Clarivate (CLVT) the Best Technology Penny Stock to Buy Right Now?
Mar-18-25 04:00AM - Clarivate Partners with Iprova to Streamline the Invention Creation and Submission Process
Mar-12-25 04:00AM - Clarivate Reveals Top 100 Global Innovators 2025
Feb-27-25 03:00AM - Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America
Feb-25-25 07:34PM - Analyst Report: Clarivate Plc
Feb-19-25 01:27PM - Analyst Report: Clarivate Plc
Feb-19-25 01:27PM 06:00AM - Clarivate Reports Fourth Quarter and Full Year 2024 Results
Feb-18-25 03:00AM - Clarivate Unveils Transformative Subscription-Based Access Strategy for Academia

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-03-03T18:00:00Z - Global Artificial Intelligence in Drug Commercialization Market to Observe Stupendous Growth at a CAGR of ~24% by 2032 | DelveInsight
B2 - 2024-09-18T11:41:56Z - Clarivate Partners With Libraries To Unveil AI Research Assistant, Boosting Academic Integrity And Discovery
B3 - 2024-07-22T14:31:59Z - Clarivate (CLVT) to Develop Unified Library Solution for Ohio - Zacks Investment Research
B4 - 2024-05-09T13:00:13Z - Critical Insights From Clarivate Analyst Ratings: What You Need To Know
B5 - 2024-05-08T13:30:27Z - Compared to Estimates, Clarivate (CLVT) Q1 Earnings: A Look at Key Metrics
B6 - 2024-05-08T11:15:07Z - Clarivate PLC (CLVT) Q1 Earnings Meet Estimates

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Clarivate (CLVT).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

CLVT_OUT_3 [2025-04-29 10:01:42 -0400] 1131 Bytes | 262 tokens | Cum: 1641 tkns (20.51% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Global Artificial Intelligence in Drug Commercialization Market to Observe Stupendous Growth at a CAGR of ~24% by 2032 | DelveInsight**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/03/03/3035901/0/en/Global-Artificial-Intelligence-in-Drug-Commercialization-Market-to-Observe-Stupendous-Growth-at-a-CAGR-of-24-by-2032-DelveInsight.htmlThe increasing prevalence of chronic diseases is driving the demand for advanced and effective treatments, highlighting the need for AI-powered drug commercialization. Pharmaceutical companies are leveraging AI for personalized medicine, improving drug development and market strategy. Rising partnerships between technology providers and pharmaceutical firms are accelerating AI adoption, strengthening data analytics, and optimizing commercialization efforts.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLVT_OUT_5 [2025-04-29 10:01:43 -0400] 917 Bytes | 288 tokens | Cum: 1931 tkns (24.14% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-29T12:18:00Z - Clarivate PLC (CLVT) Q1 Earnings and Revenues Surpass Estimates...
A2 - 2025-04-29T12:07:17Z - 12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Aqua Metals (NASDAQ:AQMS), Clarivate ...
A3 - 2025-04-29T11:52:43Z - Clarivate Q1 Loss Widens, Reaffirms FY Guidance; Stock Up In Pre-market...
A4 - 2025-04-29T10:34:11Z - Clarivate Reports First Quarter 2025 Results...
A5 - 2025-04-29T10:10:16Z - Clarivate Analytics Non-GAAP EPS of $0.14 beats by $0.02, revenue of $593.7M beats by $23.34M (CLVT:...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CLVT_OUT_7 [2025-04-29 10:01:44 -0400] 1181 Bytes | 311 tokens | Cum: 2244 tkns (28.05% of 8k)
==========================================================================

Showing A1 (chunk 1 of 6): A1:
**Clarivate PLC (CLVT) Q1 Earnings and Revenues Surpass Estimates**Date: 2025-04-29Source: {'uri': 'nasdaq.com', 'dataType': 'news', 'title': 'NASDAQ Stock Market'}URL: https://www.nasdaq.com/articles/clarivate-plc-clvt-q1-earnings-and-revenues-surpass-estimatesClarivate PLC (CLVT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this company would post earnings of $0.20 per share when it actually produced earnings of $0.21, delivering a surprise of 5%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Clarivate, which belongs to the Zacks Computers - IT Services industry,

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLVT_OUT_9 [2025-04-29 10:01:45 -0400] 1181 Bytes | 274 tokens | Cum: 2520 tkns (31.50% of 8k)
==========================================================================

Showing A1 (chunk 2 of 6): posted revenues of $593.7 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.56%. This compares to year-ago revenues of $621.2 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Clarivate shares have lost about 29.3% since the beginning of the year versus the S&P 500's decline of -6%.

What's Next for Clarivate?

While Clarivate has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does t

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLVT_OUT_11 [2025-04-29 10:01:46 -0400] 1181 Bytes | 253 tokens | Cum: 2775 tkns (34.69% of 8k)
==========================================================================

Showing A1 (chunk 3 of 6): his include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Clarivate: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLVT_OUT_13 [2025-04-29 10:01:46 -0400] 1181 Bytes | 286 tokens | Cum: 3063 tkns (38.29% of 8k)
==========================================================================

Showing A1 (chunk 4 of 6): here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.17 on $590.95 million in revenues for the coming quarter and $0.64 on $2.33 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computers - IT Services is currently in the bottom 44% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Cerence (CRNC), another stock in the same industry, has yet to report results for the quarter ended March 2025. The results are expected to be released on May 7.

This automotive artificial intelligence developer

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLVT_OUT_15 [2025-04-29 10:01:47 -0400] 1181 Bytes | 303 tokens | Cum: 3368 tkns (42.10% of 8k)
==========================================================================

Showing A1 (chunk 5 of 6): is expected to post quarterly earnings of $0.34 per share in its upcoming report, which represents a year-over-year change of +477.8%. The consensus EPS estimate for the quarter has been revised 7.4% lower over the last 30 days to the current level.

Cerence's revenues are expected to be $76.02 million, up 12.1% from the year-ago quarter.

Should You Invest in Clarivate PLC (CLVT)?

Before you invest in Clarivate PLC (CLVT), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.

Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLVT_OUT_17 [2025-04-29 10:01:49 -0400] 682 Bytes | 164 tokens | Cum: 3534 tkns (44.17% of 8k)
==========================================================================

Showing A1 (chunk 6 of 6): 024.)

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLVT_OUT_19 [2025-04-29 10:01:50 -0400] 796 Bytes | 234 tokens | Cum: 3770 tkns (47.12% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-29 8-K Item 2.02. Results of Oper and Fin Cond.

On April 29, 2025, Clarivate Plc (the Company) issued a press release announcing earnings for the first quarter ended March 31, 2025. The press release has been furnished with this Form 8-K as Exhibit 99.1 and is posted ...

S2 - 2025-04-29 10-Q PART I. Fin Information

Item 1. Fin Stmnts.

CLARIVATE PLC

Condensed Cons Balance Sheets (Unaudited)

(In millions)

March 31, 2025 December 31, 2024 ASSETS Curr assets: Cash and cash equiv, including restricted cash $ 354.0 $ 295.2 Accoun...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CLVT_OUT_21 [2025-04-29 10:01:50 -0400] 1152 Bytes | 285 tokens | Cum: 4057 tkns (50.71% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 2.02. Results of Operations and Financial Condition.

On April 29, 2025, Clarivate Plc (the Company) issued a press release announcing earnings for the first quarter ended March 31, 2025. The press release has been furnished with this Form 8-K as Exhibit 99.1 and is posted on the investor relations section of the Companys website ( http://ir.clarivate.com/ ).

The information in this Item 2.02, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any filing pursuant to the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as otherwise expressly stated in such filing....

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CLVT_OUT_23 [2025-04-29 10:01:59 -0400] 7095 Bytes | 2012 tokens | Cum: 6071 tkns (75.89% of 8k)
==========================================================================

This is our set of metrics for Clarivate.
Please analyze the numbers.

+-------------------+-----------------------+-------------------------+-----------------------+
| Volume: 899,829 | Perf Month: 3.38% | Option/Short: Yes / Yes | Sales Y/Y TTM: -2.74% |
+-------------------+-----------------------+-------------------------+-----------------------+
| Avg Volume: 6.63M | Perf Quarter: -26.05% | Short Float: 11.60% | ROE: -11.44% |
+-------------------+-----------------------+-------------------------+-----------------------+
| Rel Volume: 1.53 | Index: - | Short Ratio: 6.84 | ROI: -6.88% |
+-------------------+-----------------------+-------------------------+-----------------------+
| RSI (14): 60.12 | Market Cap: 2.83B | Short Interest: 45.34M | Sales Surprise: 0.43% |
+-------------------+-----------------------+-------------------------+-----------------------+
| ATR (14): 0.28 | Shs Outstand: 691.40M | Beta: 1.53 | EPS Surprise: 3.65% |
+-------------------+-----------------------+-------------------------+-----------------------+
| SMA20: 17.05% | Shs Float: 390.89M | Sales Q/Q: -3.03% | P/E: - |
+-------------------+-----------------------+-------------------------+-----------------------+
| SMA50: 3.24% | Inst Own: 65.51% | Sales past 5Y: 23.24% | Earnings: Apr 29 BMO |
+-------------------+-----------------------+-------------------------+-----------------------+
| SMA200: -24.45% | Insider Own: 43.26% | Employees: 12000 | |
+-------------------+-----------------------+-------------------------+-----------------------+
| Perf Week: 24.74% | Insider Trans: 1.30% | Debt/Eq: 0.89 | |
+-------------------+-----------------------+-------------------------+-----------------------+

The next section covers any insider trading by Clarivate officers or majority shareholders (if available).

Inside Trans: CLARIVATE PLC (CLVT) by Bomba Jane L Okun (Unknown Title) on 2025-03-31
- Ordinary Shares: 7315 shares at $3.93 (D)
- Ordinary Shares: 404 shares at $3.93 (D)

Inside Trans: CLARIVATE PLC (CLVT) by Snyder Andrew Miles (Unknown Title) on 2025-03-31
- Ordinary Shares: 13040 shares at $3.93 (D)
- Ordinary Shares: 840 shares at $3.93 (D)

Inside Trans: CLARIVATE PLC (CLVT) by Snyder Andrew Miles (Unknown Title) on 2025-03-14
- Ordinary Shares: 237176 shares at $4.17 (I)

Inside Trans: CLARIVATE PLC (CLVT) by Levy Henry (President, LS&H) on 2025-03-15
- Ordinary Shares: 242130 shares at $0 (D)

Inside Trans: CLARIVATE PLC (CLVT) by Veinstein Bar (President, A&G) on 2025-03-15
- Ordinary Shares: 242130 shares at $0 (D)

Inside Trans: CLARIVATE PLC (CLVT) by Samson James Gordon (President, IP) on 2025-03-15
- Ordinary Shares: 242130 shares at $0 (D)

Inside Trans: CLARIVATE PLC (CLVT) by Shem Tov Matitiahu S. (Chief Executive Officer) on 2025-03-15
- Ordinary Shares: 726392 shares at $0 (D)

Inside Trans: CLARIVATE PLC (CLVT) by Easton Michael M (Senior VP, Finance/CAO) on 2025-03-15
- Ordinary Shares: 208837 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 2577400000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -1288800000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 4.225
Average Volume: 6453535.0
30-Day High: 4.225
30-Day Low: 3.1

[Detailed Financials: Q3 2024]
- Total Assets: $12,030,600,000.00
- Total Liabilities: $6,517,100,000.00
- Total Equity: $5,513,500,000.00
- Current Assets: $1,339,100,000.00
- Current Liabilities: $1,525,600,000.00

[Income Statement: Q3 2024]
- Revenue: $622,200,000.00
- Net Income: $-65,600,000.00
- Gross Profit: $412,100,000.00
- Operating Income: $21,700,000.00
- Earnings Per Share (EPS): -0.09

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $12,100,000.00

[Detailed Financials: Q2 2024]
- Total Assets: $12,077,700,000.00
- Total Liabilities: $6,473,100,000.00
- Total Equity: $5,604,600,000.00
- Current Assets: $1,334,800,000.00
- Current Liabilities: $1,485,100,000.00

[Income Statement: Q2 2024]
- Revenue: $650,300,000.00
- Net Income: $-304,300,000.00
- Gross Profit: $436,700,000.00
- Operating Income: $-240,000,000.00
- Earnings Per Share (EPS): -0.46

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-4,600,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Clarivate (CLVT).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Clarivate.

2) MARKET_SCORE[]
This conversation was initiated because CLVT is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for CLVT.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, CLVT could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect CLVT to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Clarivate.

11) ETHICAL_RATING[]
Rate Clarivate’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Clarivate.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

CLVT_IN_25 [2025-04-29 10:01:59 -0400] 126 Bytes | 29 tokens | Cum: 6296 tkns (78.70% of 8k)
==========================================================================

====================================
[2025-04-29 10:01:59] # Analysis Completed
Elapsed Time: 19.59 seconds